000			02191 a2200613 4500
005			20250516084839.0
264		0	_c20120827
008			201208s 0 0 eng d
022			_a1096-1186
024	7		_a10.1016/j.phrs.2012.03.013 _2doi
040			_aNLM _beng _cNLM
100	1		_aYousef, Mohammad
245	0	0	_aChitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action. _h[electronic resource]
260			_bPharmacological research _cJul 2012
300			_a66-79 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAcetic Acid
650	0	4	_aAcute Disease
650	0	4	_aAdministration, Oral
650	0	4	_aAnimals
650	0	4	_aAnti-Inflammatory Agents _xadministration & dosage
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aCell Line
650	0	4	_aChitosan _xadministration & dosage
650	0	4	_aChronic Disease
650	0	4	_aColitis _xchemically induced
650	0	4	_aColon _xdrug effects
650	0	4	_aDextran Sulfate
650	0	4	_aDisease Models, Animal
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDown-Regulation
650	0	4	_aGastrointestinal Agents _xadministration & dosage
650	0	4	_aHumans
650	0	4	_aInflammation Mediators _xmetabolism
650	0	4	_aInflammatory Bowel Diseases _xchemically induced
650	0	4	_aInterleukin-6 _xmetabolism
650	0	4	_aIntestinal Mucosa _xdrug effects
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMice, Inbred ICR
650	0	4	_aNF-kappa B _xmetabolism
650	0	4	_aOxidative Stress _xdrug effects
650	0	4	_aPermeability
650	0	4	_aReactive Oxygen Species _xmetabolism
650	0	4	_aSignal Transduction _xdrug effects
650	0	4	_aTime Factors
650	0	4	_aTumor Necrosis Factor-alpha _xmetabolism
700	1		_aPichyangkura, Rath
700	1		_aSoodvilai, Sunhapas
700	1		_aChatsudthipong, Varanuj
700	1		_aMuanprasat, Chatchai
773	0		_tPharmacological research _gvol. 66 _gno. 1 _gp. 66-79
856	4	0	_uhttps://doi.org/10.1016/j.phrs.2012.03.013 _zAvailable from publisher's website
999			_c21677963 _d21677963